Association of polymorphism of ser311cys paraoxonase-2 gene with type 2 diabetes mellitus in Iran

International Journal of Preventive Medicine

Volumn 4, Issue 5, 2013, Pages 517-522

  Andalib, Sasan ^a   Vaseghi, Golnaz ^b   Motavallian, Azadeh ^c   Sadeghi, Hamid Mirmohamad ^b   Eshraghi, Azadeh ^b   Amini, Masoud ^b   Majlesi, Amir Reza ^d  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c GUILAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Iranian population; Paraxonase 2 gene; Polymorphism; Type 2 diabetes

Indexed keywords

ARYLDIALKYLPHOSPHATASE 2; CYSTEINE; GENOMIC DNA; SERINE;

ADULT; ARTICLE; ARYLDIALKYLPHOSPHATASE 2 GENE; CONTROLLED STUDY; DNA EXTRACTION; DNA POLYMORPHISM; FEMALE; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HOMOZYGOSITY; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEQUENCE ANALYSIS;

EID: 84879593136     PISSN: 20087802     EISSN: 20088213     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Prochazka M, Thompson DB, Scherer SW. Linkage and association of insulin resistance and NIDDM with markers at 7q21.3q22.1 in the pimaindians. Diabetes 1995;44:42.
2. Primo-Parma SL. The human serum paraoxonase/ arylesterase gene (PON1) is one member of a multigene family. Genomics 1996;33:498-509.
3. Ng CJ, Wadleigh DJ, Gangopadhyay A, Hama S, Grijalva VR, Navab M, et al. Paraoxonase-2 is a ubiquitously expressed protein with antioxidant properties and is capable of preventing cell-mediated oxidative modification of low density lipoprotein. J Biol Chem 2001;276:44444-44449.
4. Draganov DI, Stetson PL, Watson CE, Billecke SS, La Du BN. Rabbit serum paraoxonase 3 (PON3) is a high density lipoprotein-associated lactonase and protects low density lipoprotein against oxidation. J Biol Chem 2000;275:33435-33442.
5. Reddy ST, Wadleigh DJ, Grijalva V, Ng C, Hama S, Gangopadhyay A, et al. Human paraoxonase-3 is an HDL-associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidized lipids. Arterioscler Thromb Vasc Biol 2001;21:542-547.
6. Ruiz J, Blanche H, James RW, Garin MC, Vaisse C, Charpentier G, et al. Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes. Lancet 1995;346:869-872.
7. Zama T, Murata M, Matsubara Y, Kawano K, Aoki N, Yoshino H, et al. A192Arg variant of the human paraoxonase (HUMPONA) gene polymorphism is associated with an increased risk for coronary artery disease in the Japanese. Arterioscler Thromb Vasc Biol 1997;17:3565-3569.
8. Masato O, Yoichi T, Kamejiro Y. Paraoxonase polymorphism (Gln192-Arg) is associated with coronary heart disease. J Clin Endocrinol Metab 1997;82:2257-2260.
9. Hegele RA, Connelly PW, Scherer SW, Hanley AJ, Harris AB, Tsui LC, et al. Paraoxonase-2 gene (PON2) G148 variant associated with elevated fasting plasma glucose in noninsulin-dependent diabetes mellitus. J Clin Endocrino lMetab 1997;82:3373-7.
10. Sureerut P, Thinnakorn P, Wanida S. Human Paraoxanase 2. Excli J 2010;9:159-172.
11. Horke S, Witte I, Wilgenbus P, Altenhöfer S, Krüger M, Li H, et al. Protective effect of paraoxonase-2 against endoplasmic reticulumstress-induced apoptosis is lost upon disturbance of calcium homoeostasis. Biochem J 2008;416:395-405.
12. Qu Y, Yang Z, Jin F, Sun L, Zhang C, Ji L, et al. The Ser311Cys variation in the paraoxonase 2 gene increases the risk of type 2 diabetes in northern Chinese. J Genet 2008;87:165-169.
13. Sanghera DK, Aston CE, Saha N, Kamboh MI. DNA polymorphisms in two paraoxonase genes (PON1 and PON2) is associated with the risk of coronary heart disease. Am J Hum Genet 1998;62:36-44.
14. Mackness B, Durrington PN, Abuashia B, Boulton AJ, Mackness MI. Low paraoxonase activity in type II diabetes mellitus complicated by retinopathy. Clin Sci (Lond) 2000;98:355-363.
15. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
16. Altenhöfer S, Witte I, Teiber JF, Wilgenbus P, Pautz A, Li H, et al. One enzyme, two functions: PON2 prevents mitochondrial superoxide formation and apoptosis independent from its lactonase activity. J Biol Chem 2010;285:398-403.
17. Mochizuki H, Scherer SW, Xi T, Nickle DC, Majer M, Huizenga JJ, et al. Human PON2 gene at 7q21.3: Cloning, multiplem RNA forms, and missense polymorphisms in the coding sequence. Gene 1998;213:149-157.
18. Mackness B, Mcelduff P, Mackness MI. The paraoxonase-2-310 polymorphism is associated with the presence of microvascular complications in diabetes mellitus. J Intern Med 2005;258:363-368.
19. Ikeda Y, Suehiro T, Ohsaki F, Arii K, Kumon Y, Hashimoto K. Relationship between polymorphisms of the human serum paraoxonase gene and insulin sensivity in Japanese patients with type 2 diabetes. Diabetes Res Clin Pract 2003;60:79-85.
20. Robertson KS, Hawe E, Miller GJ, Talmud PJ, Humphries SE. Human paraoxonase gene cluster polymorphisms as predictors of coronary heart disease risk in the prospective Northwick Park Heart Study II. Biochim BiophysActa 2003;1639:203-212.
21. Jalilian A, Javadi E, Akrami M, Fakhrzadeh H, Heshmat R, Rahmani M, et al. Association of Cys 311 Ser polymorphism of Paraoxonase-2 gene with the risk of coronary artery disease. Arch Iran Med 2008;11:544-549.
22. Leus FR, Zwart M, Kastelein JJ, Voorbij HA. PON2 gene variants are associated with clinical manifestations of cardiovascular disease in familial hypercholesterolemia patients. Atherosclerosis 2001;154:641-649.